NCT05846464 is a NA clinical trial of Meta Quest 2 in Injuries to the Hand and Wrist, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

Who is sponsoring NCT05846464?

NCT05846464 is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

What drugs are being tested in NCT05846464?

Interventions in NCT05846464: Meta Quest 2.

What condition does NCT05846464 study?

NCT05846464 studies Injuries to the Hand and Wrist.

Is NCT05846464 still recruiting?

NCT05846464 is currently completed. Last updated 14 March 2025.

Last reviewed 2025-03-14 · How we verify

NCT05846464

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Virtual Reality to Enhance Upper Extremity Physical Therapy and Recovery

Completed NA Last updated 14 March 2025

What this trial tests

NA trial testing Meta Quest 2 in Injuries to the Hand and Wrist in 9 participants. Completed in 1 December 2023.

Timeline

13 March 2023

Primary endpoint
30 November 2023

1 December 2023

Quick facts

Lead sponsor	Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	9
Start date	13 March 2023
Primary completion	30 November 2023
Estimated completion	1 December 2023
Sites	1 location across United States

Drugs / interventions tested

Meta Quest 2

Conditions studied

Injuries to the Hand and Wrist — all drugs for Injuries to the Hand and Wrist →

Sponsor

Henry M. Jackson Foundation for the Advancement of Military Medicine

Who can join

Adults 18 to 65, any sex, with Injuries to the Hand and Wrist. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a descriptive study assessing the feasibility of using VR rehabilitation with unilateral (or bilateral) impairment of the arm, wrist and or hand resulting in reduced range of motion, dexterity, and/or strength of the hand.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Henry M. Jackson Foundation for the Advancement of Military Medicine trials

Trials by the same sponsor.

NCT07223684 — TDAP in Burn Patients (Group 2) · not yet recruiting
NCT07249762 — Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robu · not yet recruiting
NCT06921707 — Pilot Trial for WounDx™ Clinical Decision Support Tool · NA · recruiting
NCT06885554 — Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation · NA · recruiting
NCT06855186 — Symptom-Targeted Approach to Rehabilitation for Concussion (STAR-C) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05846464 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Henry M. Jackson Foundation for the Advancement of Military Medicine
Last refreshed: 14 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05846464.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing